Loxo@Lilly

Loxo@Lilly is committed to the advancement of cancer treatment through innovative, targeted therapies that are uniquely designed to address the specific genetic drivers of the disease. With a personalized focus on the molecular underpinnings, they are transforming the field – backed by the power of Eli Lilly’s research capabilities.